Nasus Pharma Ltd. Tangible Net Worth Ratio
Nasus Pharma Ltd. tangible net worth ratio. Nasus Pharma Ltd. (NSRX) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($2.77 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Nasus Pharma Ltd. (NSRX) balance sheet quality index to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Nasus Pharma Ltd. (2025–2025)
Tangible net worth ratio of Nasus Pharma Ltd. from 2025 to 2025. This chart shows how Nasus Pharma Ltd.'s Tangible Net Worth Ratio has changed across 1 annual periods from 2025 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $2.77 Million with intangible assets of $0.00 USD. See NSRX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Nasus Pharma Ltd. Tangible Net Worth Ratio by Year (2025–2025)
Nasus Pharma Ltd. tangible net worth ratio by year from 2025 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Nasus Pharma Ltd. from 2025 to 2025, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see NSRX company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $2.77 Million | $0.00 | $5.00 Million | — |